The ASCO Patient-Centered Cancer Care Certification is a new, two-year pilot that will certify outpatient oncology group practices and health systems that meet a single set of comprehensive, expert-backed standards for patient-centered care delivery.
The pilot includes 88 cancer care sites and nearly 500 oncologists from 12 participating practice groups and health systems in a variety of settings, including community, hospital, and academic settings.
Throughout the measurement period, participating practices will use the ASCO Quality Reporting Registry (AQRR), a new data registry platform powered by CancerLinQ®, for ongoing measurement of quality, outcomes, and utilization measures from electronic health records, insurance claims, patient satisfaction surveys, and clinical pathways systems.
Practices will be certified by the ASCO Certification Program based on adherence to the published ASCO-COA Oncology Home Standards.
ASCO anticipates awarding the first set of certifications by Spring/Summer 2022. Pending successful completion of the pilot, ASCO then plans to open the certification to other participants.
ASCO-COA Oncology Medical Home Standards
The pilot is based on oncology medical home standards from ASCO and the Community Oncology Alliance (COA). These standards, which were published in JCO Oncology Practice in July 2021 aim to establish core elements needed to deliver equitable, high-quality cancer care and achieve broad consensus among all stakeholders on what patients with cancer should expect and receive from their cancer care teams. The OMH standards focus on seven different domains of cancer care, including patient engagement; availability and access to care; evidence-based medicine; equitable and comprehensive team-based care; quality improvement; goals of care, palliative and end-of-life care discussions; and chemotherapy safety.
Participating Practices and Payers
Participating oncology practices and payers include:
- Blue Ridge Cancer Care, Roanoke, VA
- Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI
- Central Georgia Cancer Care, Macon, GA
- Hematology-Oncology Associates of CNY, East Syracuse, NY
- Memorial Cancer Institute, Hollywood, FL
- Nebraska Hematology-Oncology, PC, Lincoln, NE
- New England Cancer Specialists, Scarborough, ME
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia, PA
- Tennessee Oncology, a partner of One Oncology, Nashville, TN
- The Center for Cancer and Blood Disorders, Fort Worth, TX
- University of Colorado Cancer Center, Aurora, CO
- Yale-New Haven Health, Smilow Cancer Hospital, New Haven, CT
Anthem, a national payer, has also signed on to participate and will share hospital utilization, drug utilization, and other data for a number of practices in order to monitor the impact of the pilot on cost and outcomes. Additional payers may be added during the initial pilot period.
- July 1, 2021 – Pilot launches
- Fall/Winter 2021 – Measure periods and site surveys conducted
- Spring 2022 – Certification award to practices
- Summer 2022 – Ongoing assessment and improvement activities begin
- Summer 2023 – Pilot completion and assessment
To learn more about the pilot and future Oncology Medical Home offerings from ASCO, please contact email@example.com.
For questions about ASCO Quality Reporting Registry, please contact firstname.lastname@example.org.